journal
https://read.qxmd.com/read/33773637/genetic-basis-of-lacunar-stroke-a-pooled-analysis-of-individual-patient-data-and-genome-wide-association-studies
#1
Matthew Traylor, Elodie Persyn, Liisa Tomppo, Sofia Klasson, Vida Abedi, Mark K Bakker, Nuria Torres, Linxin Li, Steven Bell, Loes Rutten-Jacobs, Daniel J Tozer, Christoph J Griessenauer, Yanfei Zhang, Annie Pedersen, Pankaj Sharma, Jordi Jimenez-Conde, Tatjana Rundek, Raji P Grewal, Arne Lindgren, James F Meschia, Veikko Salomaa, Aki Havulinna, Christina Kourkoulis, Katherine Crawford, Sandro Marini, Braxton D Mitchell, Steven J Kittner, Jonathan Rosand, Martin Dichgans, Christina Jern, Daniel Strbian, Israel Fernandez-Cadenas, Ramin Zand, Ynte Ruigrok, Natalia Rost, Robin Lemmens, Peter M Rothwell, Christopher D Anderson, Joanna Wardlaw, Cathryn M Lewis, Hugh S Markus
BACKGROUND: The genetic basis of lacunar stroke is poorly understood, with a single locus on 16q24 identified to date. We sought to identify novel associations and provide mechanistic insights into the disease. METHODS: We did a pooled analysis of data from newly recruited patients with an MRI-confirmed diagnosis of lacunar stroke and existing genome-wide association studies (GWAS). Patients were recruited from hospitals in the UK as part of the UK DNA Lacunar Stroke studies 1 and 2 and from collaborators within the International Stroke Genetics Consortium...
March 25, 2021: Lancet Neurology
https://read.qxmd.com/read/33773636/identifying-novel-genetic-risk-loci-for-lacunar-stroke
#2
Reinhold Schmidt, Edith Hofer
No abstract text is available yet for this article.
March 25, 2021: Lancet Neurology
https://read.qxmd.com/read/33770529/lessons-for-clinical-trial-design-in-friedreich-s-ataxia
#3
Masha G Savelieff, Eva L Feldman
No abstract text is available yet for this article.
March 23, 2021: Lancet Neurology
https://read.qxmd.com/read/33770528/epilepsy-care-in-china-and-its-relevance-for-other-countries
#4
Fernando Cendes
No abstract text is available yet for this article.
March 23, 2021: Lancet Neurology
https://read.qxmd.com/read/33770527/progression-characteristics-of-the-european-friedreich-s-ataxia-consortium-for-translational-studies-efacts-a-4-year-cohort-study
#5
Kathrin Reetz, Imis Dogan, Ralf-Dieter Hilgers, Paola Giunti, Michael H Parkinson, Caterina Mariotti, Lorenzo Nanetti, Alexandra Durr, Claire Ewenczyk, Sylvia Boesch, Wolfgang Nachbauer, Thomas Klopstock, Claudia Stendel, Francisco Javier Rodríguez de Rivera Garrido, Christian Rummey, Ludger Schöls, Stefanie N Hayer, Thomas Klockgether, Ilaria Giordano, Claire Didszun, Myriam Rai, Massimo Pandolfo, Jörg B Schulz
BACKGROUND: The European Friedreich's Ataxia Consortium for Translational Studies (EFACTS) investigates the natural history of Friedreich's ataxia. We aimed to assess progression characteristics and to identify patient groups with differential progression rates based on longitudinal 4-year data to inform upcoming clinical trials in Friedreich's ataxia. METHODS: EFACTS is a prospective, observational cohort study based on an ongoing and open-ended registry. Patients with genetically confirmed Friedreich's ataxia were seen annually at 11 clinical centres in seven European countries (Austria, Belgium, France, Germany, Italy, Spain, and the UK)...
March 23, 2021: Lancet Neurology
https://read.qxmd.com/read/33765421/antithrombotic-therapy-for-cervical-arterial-dissection
#6
Scott E Kasner
No abstract text is available yet for this article.
March 22, 2021: Lancet Neurology
https://read.qxmd.com/read/33765420/aspirin-versus-anticoagulation-in-cervical-artery-dissection-treat-cad-an-open-label-randomised-non-inferiority-trial
#7
Stefan T Engelter, Christopher Traenka, Henrik Gensicke, Sabine A Schaedelin, Andreas R Luft, Barbara Goeggel Simonetti, Urs Fischer, Patrik Michel, Gaia Sirimarco, Georg Kägi, Jochen Vehoff, Krassen Nedeltchev, Timo Kahles, Lars Kellert, Sverre Rosenbaum, Regina von Rennenberg, Roman Sztajzel, Stephen L Leib, Simon Jung, Jan Gralla, Nicole Bruni, David Seiffge, Katharina Feil, Alexandros A Polymeris, Levke Steiner, Janne Hamann, Leo H Bonati, Alex Brehm, Gian Marco De Marchis, Nils Peters, Christoph Stippich, Christian H Nolte, Hanne Christensen, Susanne Wegener, Marios-Nikos Psychogios, Marcel Arnold, Philippe Lyrer
BACKGROUND: Cervical artery dissection is a major cause of stroke in young people (aged <50 years). Historically, clinicians have preferred using oral anticoagulation with vitamin K antagonists for patients with cervical artery dissection, although some current guidelines-based on available evidence from mostly observational studies-suggest using aspirin. If proven to be non-inferior to vitamin K antagonists, aspirin might be preferable, due to its ease of use and lower cost. We aimed to test the non-inferiority of aspirin to vitamin K antagonists in patients with cervical artery dissection...
March 22, 2021: Lancet Neurology
https://read.qxmd.com/read/33740440/correction-to-lancet-neurol-2021-20-193-20
#8
(no author information available yet)
No abstract text is available yet for this article.
March 16, 2021: Lancet Neurology
https://read.qxmd.com/read/33647246/safety-and-efficacy-of-intensive-blood-pressure-lowering-after-successful-endovascular-therapy-in-acute-ischaemic-stroke-bp-target-a-multicentre-open-label-randomised-controlled-trial
#9
Mikael Mazighi, Sebastien Richard, Bertrand Lapergue, Igor Sibon, Benjamin Gory, Jerome Berge, Arturo Consoli, Julien Labreuche, Jean-Marc Olivot, Joseph Broderick, Alain Duhamel, Emmanuel Touze, Adnan I Qureshi, Amélie Yavchitz, Simon Escalard, Jean-Philippe Desilles, Hocine Redjem, Stanislas Smajda, Robert Fahed, Solène Hébert, Benjamin Maïer, François Delvoye, Perrine Boursin, Malek Ben Maacha, Michael Obadia, Candice Sabben, Raphael Blanc, Julien Savatovsky, Michel Piotin
BACKGROUND: High systolic blood pressure after successful endovascular therapy for acute ischaemic stroke is associated with increased risk of intraparenchymal haemorrhage. However, no randomised controlled trials are available to guide optimal management. We therefore aimed to assess whether an intensive systolic blood pressure target resulted in reduced rates of intraparenchymal haemorrhage compared with a standard systolic blood pressure target. METHODS: We did a multicentre, open-label, randomised controlled trial at four academic hospital centres in France...
February 26, 2021: Lancet Neurology
https://read.qxmd.com/read/33647245/blood-pressure-management-after-endovascular-therapy
#10
Wendy C Ziai, Mais Al-Kawaz
No abstract text is available yet for this article.
February 26, 2021: Lancet Neurology
https://read.qxmd.com/read/33639092/correction-to-lancet-neurology-2021-20-235-46
#11
(no author information available yet)
No abstract text is available yet for this article.
February 24, 2021: Lancet Neurology
https://read.qxmd.com/read/33600767/menstrual-migraine-a-distinct-disorder-needing-greater-recognition
#12
REVIEW
Kjersti Grøtta Vetvik, E Anne MacGregor
The term menstrual migraine refers to migraine that is associated with menstruation by more than chance, but it does not define pathophysiology. Menstrual migraine affects about 20-25% of female migraineurs in the general population, and 22-70% of patients presenting to headache clinics. In women diagnosed with menstrual migraine, perimenstrual migraine attacks are associated with substantially greater disability than their non-menstrual attacks. Loose interpretation of diagnostic criteria has led to conflicting results in studies on prevalence figures, clinical characteristics, and response to treatment...
February 15, 2021: Lancet Neurology
https://read.qxmd.com/read/33581051/correction-to-lancet-neurology-2021-19-1033-42
#13
(no author information available yet)
No abstract text is available yet for this article.
February 10, 2021: Lancet Neurology
https://read.qxmd.com/read/33743240/epilepsy-in-china-major-progress-in-the-past-two-decades
#14
REVIEW
Ding Ding, Dong Zhou, Josemir W Sander, Wenzhi Wang, Shichuo Li, Zhen Hong
China has approximately 10 million people with epilepsy. There is a vast epilepsy treatment gap in China, mainly driven by deficiencies in health-care delivery and social discrimination resulting from cultural beliefs about epilepsy. WHO's Global Campaign Against Epilepsy project in China showed that it was possible to treat epilepsy in primary care settings, which was a notable milestone. The China Association Against Epilepsy has been a necessary force to stimulate interest in epilepsy care and research by the medical and scientific community...
April 2021: Lancet Neurology
https://read.qxmd.com/read/33743239/development-of-imaging-based-risk-scores-for-prediction-of-intracranial-haemorrhage-and-ischaemic-stroke-in-patients-taking-antithrombotic-therapy-after-ischaemic-stroke-or-transient-ischaemic-attack-a-pooled-analysis-of-individual-patient-data-from-cohort
#15
Jonathan G Best, Gareth Ambler, Duncan Wilson, Keon-Joo Lee, Jae-Sung Lim, Masayuki Shiozawa, Masatoshi Koga, Linxin Li, Caroline Lovelock, Hugues Chabriat, Michael Hennerici, Yuen Kwun Wong, Henry Ka Fung Mak, Luis Prats-Sanchez, Alejandro Martínez-Domeño, Shigeru Inamura, Kazuhisa Yoshifuji, Ethem Murat Arsava, Solveig Horstmann, Jan Purrucker, Bonnie Yin Ka Lam, Adrian Wong, Young Dae Kim, Tae-Jin Song, Robin Lemmens, Sebastian Eppinger, Thomas Gattringer, Ender Uysal, Zeynep Tanriverdi, Natan M Bornstein, Einor Ben Assayag, Hen Hallevi, Jeremy Molad, Masashi Nishihara, Jun Tanaka, Shelagh B Coutts, Alexandros Polymeris, Benjamin Wagner, David J Seiffge, Philippe Lyrer, Ale Algra, L Jaap Kappelle, Rustam Al-Shahi Salman, Hans R Jäger, Gregory Y H Lip, Urs Fischer, Marwan El-Koussy, Jean-Louis Mas, Laurence Legrand, Christopher Karayiannis, Thanh Phan, Sarah Gunkel, Nicolas Christ, Jill Abrigo, Thomas Leung, Winnie Chu, Francesca Chappell, Stephen Makin, Derek Hayden, David J Williams, Werner H Mess, Paul J Nederkoorn, Carmen Barbato, Simone Browning, Kim Wiegertjes, Anil M Tuladhar, Noortje Maaijwee, Anne Cristine Guevarra, Chathuri Yatawara, Anne-Marie Mendyk, Christine Delmaire, Sebastian Köhler, Robert van Oostenbrugge, Ying Zhou, Chao Xu, Saima Hilal, Bibek Gyanwali, Christopher Chen, Min Lou, Julie Staals, Régis Bordet, Nagaendran Kandiah, Frank-Erik de Leeuw, Robert Simister, Jeroen Hendrikse, Peter J Kelly, Joanna Wardlaw, Yannie Soo, Felix Fluri, Velandai Srikanth, David Calvet, Simon Jung, Vincent I H Kwa, Stefan T Engelter, Nils Peters, Eric E Smith, Hideo Hara, Yusuke Yakushiji, Dilek Necioglu Orken, Franz Fazekas, Vincent Thijs, Ji Hoe Heo, Vincent Mok, Roland Veltkamp, Hakan Ay, Toshio Imaizumi, Beatriz Gomez-Anson, Kui Kai Lau, Eric Jouvent, Peter M Rothwell, Kazunori Toyoda, Hee-Joon Bae, Joan Marti-Fabregas, David J Werring
BACKGROUND: Balancing the risks of recurrent ischaemic stroke and intracranial haemorrhage is important for patients treated with antithrombotic therapy after ischaemic stroke or transient ischaemic attack. However, existing predictive models offer insufficient performance, particularly for assessing the risk of intracranial haemorrhage. We aimed to develop new risk scores incorporating clinical variables and cerebral microbleeds, an MRI biomarker of intracranial haemorrhage and ischaemic stroke risk...
April 2021: Lancet Neurology
https://read.qxmd.com/read/33743238/onasemnogene-abeparvovec-gene-therapy-for-symptomatic-infantile-onset-spinal-muscular-atrophy-in-patients-with-two-copies-of-smn2-str1ve-an-open-label-single-arm-multicentre-phase-3-trial
#16
MULTICENTER STUDY
John W Day, Richard S Finkel, Claudia A Chiriboga, Anne M Connolly, Thomas O Crawford, Basil T Darras, Susan T Iannaccone, Nancy L Kuntz, Loren D M Peña, Perry B Shieh, Edward C Smith, Jennifer M Kwon, Craig M Zaidman, Meredith Schultz, Douglas E Feltner, Sitra Tauscher-Wisniewski, Haojun Ouyang, Deepa H Chand, Douglas M Sproule, Thomas A Macek, Jerry R Mendell
BACKGROUND: Spinal muscular atrophy type 1 is a motor neuron disorder resulting in death or the need for permanent ventilation by age 2 years. We aimed to evaluate the safety and efficacy of onasemnogene abeparvovec (previously known as AVXS-101), a gene therapy delivering the survival motor neuron gene (SMN), in symptomatic patients (identified through clinical examination) with infantile-onset spinal muscular atrophy. METHODS: STR1VE was an open-label, single-arm, single-dose, phase 3 trial done at 12 hospitals and universities in the USA...
April 2021: Lancet Neurology
https://read.qxmd.com/read/33743237/second-intravenous-immunoglobulin-dose-in-patients-with-guillain-barr%C3%A3-syndrome-with-poor-prognosis-sid-gbs-a-double-blind-randomised-placebo-controlled-trial
#17
RANDOMIZED CONTROLLED TRIAL
Christa Walgaard, Bart C Jacobs, Hester F Lingsma, Ewout W Steyerberg, Bianca van den Berg, Alexandra Y Doets, Sonja E Leonhard, Christine Verboon, Ruth Huizinga, Judith Drenthen, Samuel Arends, Ilona Kleine Budde, Ruud P Kleyweg, Krista Kuitwaard, Marjon F G van der Meulen, Johnny P A Samijn, Frederique H Vermeij, Jan B M Kuks, Gert W van Dijk, Paul W Wirtz, Filip Eftimov, Anneke J van der Kooi, Marcel P J Garssen, Cees J Gijsbers, Maarten C de Rijk, Leo H Visser, Roderik J Blom, Wim H J P Linssen, Elly L van der Kooi, Jan J G M Verschuuren, Rinske van Koningsveld, Rita J G Dieks, H Job Gilhuis, Korné Jellema, Taco C van der Ree, Henriette M E Bienfait, Catharina G Faber, Harry Lovenich, Baziel G M van Engelen, Rutger J Groen, Ingemar S J Merkies, Bob W van Oosten, W Ludo van der Pol, Willem D M van der Meulen, Umesh A Badrising, Martijn Stevens, Albert-Jan J Breukelman, Casper P Zwetsloot, Maaike M van der Graaff, Marielle Wohlgemuth, Richard A C Hughes, David R Cornblath, Pieter A van Doorn
BACKGROUND: Treatment with one standard dose (2 g/kg) of intravenous immunoglobulin is insufficient in a proportion of patients with severe Guillain-Barré syndrome. Worldwide, around 25% of patients severely affected with the syndrome are given a second intravenous immunoglobulin dose (SID), although it has not been proven effective. We aimed to investigate whether a SID is effective in patients with Guillain-Barré syndrome with a predicted poor outcome. METHODS: In this randomised, double-blind, placebo-controlled trial (SID-GBS), we included patients (≥12 years) with Guillain-Barré syndrome admitted to one of 59 participating hospitals in the Netherlands...
April 2021: Lancet Neurology
https://read.qxmd.com/read/33743236/licence-to-practise
#18
Aravinthan Varatharaj
No abstract text is available yet for this article.
April 2021: Lancet Neurology
https://read.qxmd.com/read/33743235/what-astrocytes-need-to-do
#19
Giles E Hardingham, Gabor C Petzold, Arpan R Mehta
No abstract text is available yet for this article.
April 2021: Lancet Neurology
https://read.qxmd.com/read/33743234/altaf-saadi
#20
(no author information available yet)
No abstract text is available yet for this article.
April 2021: Lancet Neurology
journal
journal
20188
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"